What's New in Health and Life Sciences
News from the European Comission
EUROPA - Research and Innovation: Medical Sciences
EUROPA - Research What's New in Health and life sciences - Medical research. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences - Medical research. The last (or, in some news readers, the first) item of this feed will take you to the Medical Research web site. For more RSS news feeds visit http://ec.europa.eu/research/index.cfm?pg=rss
For more RSS news feeds click the link above.
Are you likelier than others to develop type 2 diabetes? Lifestyle changes could dramatically reduce the risk, but you may need advice and support to make them. EU-funded researchers are trialling an affordable way for healthcare systems to make effective assistance available across entire populations - with a little help from patients' families.
An EU-funded project is integrating research resources and providing services to support access to specific mouse models for scientific investigation of the genetic foundations of human health and disease. The aim is to boost the translation of this knowledge into better treatments for patients.
EU-funded researchers studied the way attention affects how we perceive pain, in the hope of improving the performance of psychological methods for treating chronic pain for the millions of people around the world who suffer from it.
Miniscule messenger bubbles floating in all your bodily fluids could hold important insights into many complex diseases from Alzheimer's to heart disease - if they can be isolated, analysed and their messages decoded. An EU-funded researcher has made significant strides toward achieving that goal.
A wide-reaching EU-funded project is testing new anti-blood clotting treatment in patients who have suffered a brain haemorrhage. Researchers hope to reduce the risk of the patient suffering from another stroke, which would impair their quality of life and life expectancy.
Any surgical procedure can be risky, especially for older people. To minimise the dangers, EU-funded researchers have developed the world's first personalised test to assess the risk of patients developing post-surgical sensory and cognitive disorders, allowing doctors to choose the safest treatment.
Using neurons grown from stem cells, EU-funded researchers are revealing more about mutations that lead to autism, schizophrenia and intellectual disability which researchers hope will lead to new drug targets for personalised medicine.
EU-funded researchers are investigating the causes and consequences of ADHD with the aim of improving the lives of patients and reducing their risk of developing linked disorders such as depression and obesity.
Innovative biomedical technologies and biomaterials developed in an EU-funded project promise to improve the quality of life for millions of people suffering from type 1 diabetes, eliminating the need for regular insulin injections.